Stoke Therapeutics, Inc. Common Stock (STOK) is a publicly traded Healthcare sector company. As of October 5, 2026, STOK trades at $25.75 with a market cap of $1.65B and a P/E ratio of -7.58. STOK moved +0.51% today. Year to date, STOK is -19.28%; over the trailing twelve months it is +3.22%. Its 52-week range spans $5.35 to $40.22. Analyst consensus is strong buy with an average price target of $45.40. Rallies surfaces STOK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for STOK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $25.75 |
| Market Cap | $1.65B |
| P/E Ratio | -7.58 |
| EPS | $-3.38 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.22 |
| 52-Week Low | $5.35 |
| Volume | 3.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $27.59M |
| Net Income | $-207.90M |
| Gross Margin | 0.00% |
10 analysts cover STOK: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.40.